T-lymphocytes via adhesion molecules and paracrine factors

T-lymphocytes via adhesion molecules and paracrine factors refers to the integrated biological process of T-cell recruitment, extravasation, and localized signaling within tissues. This cascade is initiated by the interaction of T-cell adhesion molecules, such as integrins (e.g., VLA-4, LFA-1) and selectins, with ligands on the vascular endothelium, facilitating the movement of leukocytes from the blood into sites of inflammation (Ley et al., 2007). Once situated in the tissue, T-lymphocytes utilize paracrine factors, including various cytokines and chemokines, to communicate with neighboring cells and orchestrate a complex immune response (Abbas et al., 2022). This pathway is a major therapeutic focus in autoimmune and inflammatory diseases where T-cell infiltration drives pathology. Drugs like Natalizumab and Vedolizumab are designed to disrupt this process by targeting specific integrin subunits, thereby preventing pathogenic T-cells from entering sensitive tissues like the brain or gut (Polman et al., 2006). Because this entry describes a multi-component cellular mechanism rather than a single molecular entity, it is classified as a biological process or mechanism of action rather than a discrete therapeutic target.

Other names

T-cell traffickingLeukocyte adhesion cascadeT-lymphocyte adhesion and signalingT-cell recruitment pathway

Inhibition of T-lymphocyte migration and activation by blocking the interaction between leukocyte adhesion molecules (e.g., integrins) and their endothelial ligands, or by modulating the paracrine signaling environment (e.g., cytokine neutralization) to prevent tissue infiltration.